$2.77 -0.03 (-1.07%)
2/10/2012 4:03 PM

Enzo Biochem, Inc. (NYSE:ENZ)

CAPS Rating: 2 out of 5

The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.

Featured Broker Partners


Advertisement